drugset / Trial / NCT01028521
First in Man Clinical Study to Investigate Safety, Tolerability and Pharmacokinetics of Single Ascending Doses of CM3.1-AC100
RandomizedSingle-groupDouble-blindBasic science
Summary
A first time in man, phase I study to assess the safety, tolerability and pharmacokinetics of single ascending doses of CM3.1-AC100 in healthy male volunteers.
Timeline
- Start
- 2010-02
- Primary completion
- 2010-05
- Completion
- 2010-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CM3.1-AC100 | Peptide | — | Subcutaneous |
Indications
No indication recorded.